Tough on #Cancer not on Patients. Initiating Phase II trials on the Indenoisoquinolines, a new class of non-Camptothecins a novel anti-cancer fighting drug.

Health Care

Biotechnology

Gibson Oncology

Randall B Riggs

Clifford T Solomon

Theodore C Solomon

Elizabeth L Rogers

The Scientific Advisory Team at Gibson Oncology provides expert guidance and strategic insights for the development and progression of the Indenoisoquinolines. They evaluate clinical trial data, advise on research methodologies, and ensure that the investigational treatments align with the latest scientific advancements and regulatory standards.

Scientific Advisory Team

About

Team members

Other teams at Gibson Oncology

Leadership Team